Global Hepatitis A Vaccine Market Research Report 2020

Global Hepatitis A Vaccine Market Research Report 2020

Table of Contents
1 Hepatitis A Vaccine Market Overview
1.1 Product Overview and Scope of Hepatitis A Vaccine
1.2 Hepatitis A Vaccine Segment by Type
1.2.1 Global Hepatitis A Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Hepatitis A Vaccine Segment by Application
1.3.1 Hepatitis A Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hepatitis A Vaccine Market Size Estimates and Forecasts
1.4.1 Global Hepatitis A Vaccine Revenue 2015-2026
1.4.2 Global Hepatitis A Vaccine Sales 2015-2026
1.4.3 Hepatitis A Vaccine Market Size by Region: 2020 Versus 2026
2 Global Hepatitis A Vaccine Market Competition by Manufacturers
2.1 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Hepatitis A Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Hepatitis A Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Hepatitis A Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Hepatitis A Vaccine Market Competitive Situation and Trends
2.5.1 Hepatitis A Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Hepatitis A Vaccine Players (Opinion Leaders)
3 Hepatitis A Vaccine Retrospective Market Scenario by Region
3.1 Global Hepatitis A Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Hepatitis A Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Hepatitis A Vaccine Market Facts & Figures by Country
3.3.1 North America Hepatitis A Vaccine Sales by Country
3.3.2 North America Hepatitis A Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hepatitis A Vaccine Market Facts & Figures by Country
3.4.1 Europe Hepatitis A Vaccine Sales by Country
3.4.2 Europe Hepatitis A Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hepatitis A Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Hepatitis A Vaccine Sales by Region
3.5.2 Asia Pacific Hepatitis A Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Hepatitis A Vaccine Market Facts & Figures by Country
3.6.1 Latin America Hepatitis A Vaccine Sales by Country
3.6.2 Latin America Hepatitis A Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Hepatitis A Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Hepatitis A Vaccine Sales by Country
3.7.2 Middle East and Africa Hepatitis A Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Hepatitis A Vaccine Historic Market Analysis by Type
4.1 Global Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Hepatitis A Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Hepatitis A Vaccine Price Market Share by Type (2015-2020)
4.4 Global Hepatitis A Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Hepatitis A Vaccine Historic Market Analysis by Application
5.1 Global Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Hepatitis A Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Hepatitis A Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Hepatitis A Vaccine Business
6.1 GSK
6.1.1 Corporation Information
6.1.2 GSK Description, Business Overview and Total Revenue
6.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GSK Products Offered
6.1.5 GSK Recent Development
6.2 Merck
6.2.1 Merck Hepatitis A Vaccine Production Sites and Area Served
6.2.2 Merck Description, Business Overview and Total Revenue
6.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Merck Products Offered
6.2.5 Merck Recent Development
6.3 Sanofi
6.3.1 Sanofi Hepatitis A Vaccine Production Sites and Area Served
6.3.2 Sanofi Description, Business Overview and Total Revenue
6.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Sanofi Products Offered
6.3.5 Sanofi Recent Development
6.4 Sinovac
6.4.1 Sinovac Hepatitis A Vaccine Production Sites and Area Served
6.4.2 Sinovac Description, Business Overview and Total Revenue
6.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sinovac Products Offered
6.4.5 Sinovac Recent Development
6.5 Zhejiang Pukang
6.5.1 Zhejiang Pukang Hepatitis A Vaccine Production Sites and Area Served
6.5.2 Zhejiang Pukang Description, Business Overview and Total Revenue
6.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Zhejiang Pukang Products Offered
6.5.5 Zhejiang Pukang Recent Development
6.6 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Hepatitis A Vaccine Production Sites and Area Served
6.6.2 Changchun Institute of Biological Description, Business Overview and Total Revenue
6.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Changchun Institute of Biological Products Offered
6.6.5 Changchun Institute of Biological Recent Development
6.7 KM Biologics
6.6.1 KM Biologics Hepatitis A Vaccine Production Sites and Area Served
6.6.2 KM Biologics Description, Business Overview and Total Revenue
6.6.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 KM Biologics Products Offered
6.7.5 KM Biologics Recent Development
6.8 IMBCA
6.8.1 IMBCA Hepatitis A Vaccine Production Sites and Area Served
6.8.2 IMBCA Description, Business Overview and Total Revenue
6.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 IMBCA Products Offered
6.8.5 IMBCA Recent Development
6.9 ChangSheng
6.9.1 ChangSheng Hepatitis A Vaccine Production Sites and Area Served
6.9.2 ChangSheng Description, Business Overview and Total Revenue
6.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 ChangSheng Products Offered
6.9.5 ChangSheng Recent Development
6.10 Convac
6.10.1 Convac Hepatitis A Vaccine Production Sites and Area Served
6.10.2 Convac Description, Business Overview and Total Revenue
6.10.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Convac Products Offered
6.10.5 Convac Recent Development
7 Hepatitis A Vaccine Manufacturing Cost Analysis
7.1 Hepatitis A Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hepatitis A Vaccine
7.4 Hepatitis A Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hepatitis A Vaccine Distributors List
8.3 Hepatitis A Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Hepatitis A Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hepatitis A Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Hepatitis A Vaccine by Type (2021-2026)
10.2 Hepatitis A Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hepatitis A Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Hepatitis A Vaccine by Application (2021-2026)
10.3 Hepatitis A Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hepatitis A Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Hepatitis A Vaccine by Region (2021-2026)
10.4 North America Hepatitis A Vaccine Estimates and Projections (2021-2026)
10.5 Europe Hepatitis A Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Hepatitis A Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Hepatitis A Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Hepatitis A Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Hepatitis A Vaccine Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Hepatitis A Vaccine Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Hepatitis A Vaccine Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Hepatitis A Vaccine Manufacturers Covered in This Study
Table 5. Global Hepatitis A Vaccine Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Hepatitis A Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Hepatitis A Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Hepatitis A Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Hepatitis A Vaccine Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Hepatitis A Vaccine Sales Sites and Area Served
Table 11. Manufacturers Hepatitis A Vaccine Product Types
Table 12. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis A Vaccine as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Hepatitis A Vaccine Players
Table 16. Global Hepatitis A Vaccine Sales (K MT) by Region (2015-2020)
Table 17. Global Hepatitis A Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Hepatitis A Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Hepatitis A Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Hepatitis A Vaccine Sales by Country (2015-2020) (K MT)
Table 21. North America Hepatitis A Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Hepatitis A Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Hepatitis A Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Hepatitis A Vaccine Sales by Country (2015-2020) (K MT)
Table 25. Europe Hepatitis A Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Hepatitis A Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Hepatitis A Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Hepatitis A Vaccine Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Hepatitis A Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Hepatitis A Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Hepatitis A Vaccine Sales by Country (2015-2020) (K MT)
Table 33. Latin America Hepatitis A Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Hepatitis A Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Hepatitis A Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Hepatitis A Vaccine Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Hepatitis A Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Hepatitis A Vaccine Sales (K MT) by Type (2015-2020)
Table 41. Global Hepatitis A Vaccine Sales Share by Type (2015-2020)
Table 42. Global Hepatitis A Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Hepatitis A Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Hepatitis A Vaccine Price (USD/MT) by Type (2015-2020)
Table 45. Global Hepatitis A Vaccine Sales (K MT) by Application (2015-2020)
Table 46. Global Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Hepatitis A Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. GSK Hepatitis A Vaccine Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. GSK Main Product
Table 52. GSK Recent Development
Table 53. Merck Hepatitis A Vaccine Corporation Information
Table 54. Merck Corporation Information
Table 55. Merck Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Merck Main Product
Table 57. Merck Recent Development
Table 58. Sanofi Hepatitis A Vaccine Corporation Information
Table 59. Sanofi Corporation Information
Table 60. Sanofi Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Sanofi Main Product
Table 62. Sanofi Recent Development
Table 63. Sinovac Hepatitis A Vaccine Corporation Information
Table 64. Sinovac Corporation Information
Table 65. Sinovac Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Sinovac Main Product
Table 67. Sinovac Recent Development
Table 68. Zhejiang Pukang Hepatitis A Vaccine Corporation Information
Table 69. Zhejiang Pukang Corporation Information
Table 70. Zhejiang Pukang Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Zhejiang Pukang Main Product
Table 72. Zhejiang Pukang Recent Development
Table 73. Changchun Institute of Biological Hepatitis A Vaccine Corporation Information
Table 74. Changchun Institute of Biological Corporation Information
Table 75. Changchun Institute of Biological Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Changchun Institute of Biological Main Product
Table 77. Changchun Institute of Biological Recent Development
Table 78. KM Biologics Hepatitis A Vaccine Corporation Information
Table 79. KM Biologics Corporation Information
Table 80. KM Biologics Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. KM Biologics Main Product
Table 82. KM Biologics Recent Development
Table 83. IMBCA Hepatitis A Vaccine Corporation Information
Table 84. IMBCA Corporation Information
Table 85. IMBCA Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. IMBCA Main Product
Table 87. IMBCA Recent Development
Table 88. ChangSheng Hepatitis A Vaccine Corporation Information
Table 89. ChangSheng Corporation Information
Table 90. ChangSheng Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. ChangSheng Main Product
Table 92. ChangSheng Recent Development
Table 93. Convac Hepatitis A Vaccine Corporation Information
Table 94. Convac Corporation Information
Table 95. Convac Hepatitis A Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Convac Main Product
Table 97. Convac Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Hepatitis A Vaccine Distributors List
Table 101. Hepatitis A Vaccine Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Hepatitis A Vaccine Sales (K MT) Forecast by Type (2021-2026)
Table 106. Global Hepatitis A Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Hepatitis A Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Hepatitis A Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Hepatitis A Vaccine Sales (K MT) Forecast by Application (2021-2026)
Table 110. Global Hepatitis A Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Hepatitis A Vaccine Sales (K MT) Forecast by Region (2021-2026)
Table 112. Global Hepatitis A Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Hepatitis A Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Hepatitis A Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Hepatitis A Vaccine
Figure 2. Global Hepatitis A Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Live Attenuated Vaccine Product Picture
Figure 5. Global Hepatitis A Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Global Hepatitis A Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Hepatitis A Vaccine Sales Capacity (K MT) (2015-2026)
Figure 11. Global Hepatitis A Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Hepatitis A Vaccine Sales Share by Manufacturers in 2020
Figure 13. Global Hepatitis A Vaccine Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Hepatitis A Vaccine Revenue in 2019
Figure 15. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Hepatitis A Vaccine Sales Market Share by Region (2015-2020)
Figure 17. Global Hepatitis A Vaccine Sales Market Share by Region in 2019
Figure 18. Global Hepatitis A Vaccine Revenue Market Share by Region (2015-2020)
Figure 19. Global Hepatitis A Vaccine Revenue Market Share by Region in 2019
Figure 20. North America Hepatitis A Vaccine Sales Market Share by Country in 2019
Figure 21. North America Hepatitis A Vaccine Revenue Market Share by Country in 2019
Figure 22. U.S. Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 23. U.S. Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 25. Canada Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Hepatitis A Vaccine Sales Market Share by Country in 2019
Figure 27. Europe Hepatitis A Vaccine Revenue Market Share by Country in 2019
Figure 28. Germany Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 29. Germany Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 31. France Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.K. Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 35. Italy Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 37. Russia Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Hepatitis A Vaccine Sales Market Share by Region in 2019
Figure 39. Asia Pacific Hepatitis A Vaccine Revenue Market Share by Region in 2019
Figure 40. China Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 41. China Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 43. Japan Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 45. South Korea Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 47. India Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 49. Australia Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 51. Taiwan Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 53. Indonesia Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 55. Thailand Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 57. Malaysia Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 59. Philippines Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 61. Vietnam Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Hepatitis A Vaccine Sales Market Share by Country in 2019
Figure 63. Latin America Hepatitis A Vaccine Revenue Market Share by Country in 2019
Figure 64. Mexico Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 65. Mexico Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 67. Brazil Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 69. Argentina Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Hepatitis A Vaccine Revenue Market Share by Country in 2019
Figure 72. Turkey Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 73. Turkey Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 75. Saudi Arabia Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Hepatitis A Vaccine Sales Growth Rate (2015-2020) (K MT)
Figure 77. U.A.E Hepatitis A Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Hepatitis A Vaccine by Type (2015-2020)
Figure 79. Sales Market Share of Hepatitis A Vaccine by Type in 2019
Figure 80. Revenue Share of Hepatitis A Vaccine by Type (2015-2020)
Figure 81. Revenue Market Share of Hepatitis A Vaccine by Type in 2019
Figure 82. Global Hepatitis A Vaccine Sales Growth by Type (2015-2020) (K MT)
Figure 83. Global Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Figure 84. Global Hepatitis A Vaccine Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Hepatitis A Vaccine by Application (2015-2020)
Figure 86. Global Revenue Share of Hepatitis A Vaccine by Application in 2020
Figure 87. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Sinovac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Zhejiang Pukang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Changchun Institute of Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. KM Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. IMBCA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. ChangSheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Convac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Price Trend of Key Raw Materials
Figure 98. Manufacturing Cost Structure of Hepatitis A Vaccine
Figure 99. Manufacturing Process Analysis of Hepatitis A Vaccine
Figure 100. Hepatitis A Vaccine Industrial Chain Analysis
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. North America Hepatitis A Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 105. North America Hepatitis A Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Hepatitis A Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Hepatitis A Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Hepatitis A Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Hepatitis A Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Hepatitis A Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Hepatitis A Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Hepatitis A Vaccine Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Hepatitis A Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Hepatitis A Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 89

According to our LPI (LP Information) latest study, the global Hepatitis A Vaccine market size was valued at US$ 690.5 million in 2023. With growing demand in downstream market, the Hepatitis A Vaccine is forecast to a readjusted size of US$ 810.9 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Hepatitis A Vaccine market. Hepatitis A Vaccine are expected to show stable growth in the future market. However, produc......

Global Human Hepatitis B Immunoglobulin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Human Hepatitis B Immunoglobulin market: According to our latest research, the global Human Hepatitis B Immunoglobulin market looks promising in the next 5 years. As of 2022, the global Human Hepatitis B Immunoglobulin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......

Global Hepatitis A Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 85

According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at USD 726.3 million in 2023 and is forecast to a readjusted size of USD 842.5 million by 2030 with a CAGR of 2.1% during review period. Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currentl......

Global Hepatitis A Vaccine Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 ye......

Global Thymosin a1 Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 103

Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......

Global Thymosin a1 Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 136

Thymosin ?? is a peptide fragment derived from prothymosin alpha, a protein that in humans is encoded by the PTMA gene. It was the first of the peptides from Thymosin Fraction 5 to be completely sequenced and synthesized. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their ......

Global Hepatitis B Immune Globulin Market Research Report 2023

Published: 06-Nov-2023        Price: US 2900 Onwards        Pages: 85

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hepatitis B Immune Globulin market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - ADMA Biologics - Bio Products Laboratory - Grifols - Biotest AG - CSL Behring - FFF Enterprises - Cleveland Clinic Seg......

Global Sofosbuvir Market Research Report 2023

Published: 31-Oct-2023        Price: US 2900 Onwards        Pages: 94

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sofosbuvir market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Teva Pharmaceutical Industries Ltd - DONG BANG FUTURE TECH & LIFE CO., LTD - Beaukev Pharma International Pvt.Ltd - DEAFARMA - Tecoland - Anhui HaiKang Pha......

Global Hepatitis A Vaccine Market Insights, Forecast to 2029

Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 97

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs